Effect of Water Intake and Water Restriction on Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease
1 other identifier
interventional
40
1 country
1
Brief Summary
The objective of this study is to measure the influence of both short term water restriction and high water intake on total kidney volume, measured by Magnetic Resonance Imaging (MRI) scan in Autosomal Dominant Polycystic Kidney Disease (ADPKD) patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2015
CompletedFirst Submitted
Initial submission to the registry
May 4, 2016
CompletedFirst Posted
Study publicly available on registry
May 18, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2017
CompletedOctober 2, 2017
September 1, 2017
1.3 years
May 4, 2016
September 28, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in total kidney volume
Baseline and 3 hours
Secondary Outcomes (4)
Change in total cyst volume
Baseline and 3 hours
Change in plasma renin
Baseline and 3 hours
Change in plasma aldosterone
Baseline and 3 hours
Change in plasma copeptin
Baseline and 3 hours
Study Arms (2)
water restriction
NO INTERVENTION20 patients will be subjected to 3 hours of water restriction following MR scan of the kidneys.
high water intake
ACTIVE COMPARATOR20 patients will be subjected to 1 hour of high water intake (20 ml/kg) following MR scan of the kidneys.
Interventions
Eligibility Criteria
You may qualify if:
- ADPKD
- CKD stage 1-3
You may not qualify if:
- Patients treated with diuretics
- Pregnancy
- Change in antihypertensive treatment \< 1 month
- Any condition contraindicating MR scan
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rigshospitalet, Denmarklead
- Aarhus University Hospitalcollaborator
Study Sites (1)
Rigshospitalet
Copenhagen, 2100, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Signe V Naver, MD
Rigshospitalet, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
May 4, 2016
First Posted
May 18, 2016
Study Start
September 1, 2015
Primary Completion
January 1, 2017
Study Completion
January 1, 2017
Last Updated
October 2, 2017
Record last verified: 2017-09
Data Sharing
- IPD Sharing
- Will share